Risk factors for thrombosis and recommendations for thromboprophylaxis78
| Risk factors . | ||
|---|---|---|
| Treatment-related . | Patient-specific . | Myeloma-specific . |
| IMiDs | Age | Active uncontrolled disease |
| High-dose dexamethasone | Previous VTE | Hyperviscosity |
| Erythropoietin | Infection | |
| Anthracyclines | Surgical procedures | |
| Multiagent chemotherapy | Cardiovascular comorbidities | |
| Immobilization | ||
| Inherited thrombophilia | ||
| Central venous catheter | ||
| Risk factors . | ||
|---|---|---|
| Treatment-related . | Patient-specific . | Myeloma-specific . |
| IMiDs | Age | Active uncontrolled disease |
| High-dose dexamethasone | Previous VTE | Hyperviscosity |
| Erythropoietin | Infection | |
| Anthracyclines | Surgical procedures | |
| Multiagent chemotherapy | Cardiovascular comorbidities | |
| Immobilization | ||
| Inherited thrombophilia | ||
| Central venous catheter | ||
| Recommendations for thromboprophylaxis . | ||
|---|---|---|
| Risk factor . | Number of risk factors . | Therapy . |
| Treatment-specific | ≥1 | LMWH or warfarin |
| Patient-specific | 1 | ASA |
| Myeloma-specific | 1 | ASA |
| Patient- or myeloma-specific | ≥2 | LMWH or warfarin |
| Recommendations for thromboprophylaxis . | ||
|---|---|---|
| Risk factor . | Number of risk factors . | Therapy . |
| Treatment-specific | ≥1 | LMWH or warfarin |
| Patient-specific | 1 | ASA |
| Myeloma-specific | 1 | ASA |
| Patient- or myeloma-specific | ≥2 | LMWH or warfarin |